# FDA Inspection 680615 - Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc. - August 30, 2010

Source: https://www.keypedia.com/records/fda_inspections/gregory-pharmaceutical-holdings-inc-dba-upm-pharmaceuticals-inc/7c1905fd-02ae-4ffc-a1ac-f05c1d179313
Source feed: FDA_Inspections

> FDA Inspection 680615 for Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc. on August 30, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 680615
- Company Name: Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc.
- Inspection Date: 2010-08-30
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1249609 - 2024-09-20](https://www.keypedia.com/records/fda_inspections/gregory-pharmaceutical-holdings-inc-dba-upm-pharmaceuticals-inc/231dda87-df66-4fb3-98c0-660cc22f6fde)
- [FDA Inspection 1086261 - 2019-04-12](https://www.keypedia.com/records/fda_inspections/gregory-pharmaceutical-holdings-inc-dba-upm-pharmaceuticals-inc/b2f87b25-025a-4bc6-9a7b-4f3d027305ea)
- [FDA Inspection 998826 - 2016-10-28](https://www.keypedia.com/records/fda_inspections/gregory-pharmaceutical-holdings-inc-dba-upm-pharmaceuticals-inc/c5a14222-aaba-443b-a406-947326df88b0)
- [FDA Inspection 998826 - 2016-10-28](https://www.keypedia.com/records/fda_inspections/gregory-pharmaceutical-holdings-inc-dba-upm-pharmaceuticals-inc/efbd4327-52cd-49bb-a74a-7776f803c06f)
- [FDA Inspection 940674 - 2015-08-14](https://www.keypedia.com/records/fda_inspections/gregory-pharmaceutical-holdings-inc-dba-upm-pharmaceuticals-inc/0f32bec3-b49f-4dc6-95ea-b2799f5b3243)

Company: https://www.keypedia.com/companies/gregory-pharmaceutical-holdings-inc-dba-upm-pharmaceuticals-inc/abed0e84-484c-4ab7-b062-f61cc359a27e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c